{"id":60600,"date":"2023-06-23T17:40:41","date_gmt":"2023-06-23T12:10:41","guid":{"rendered":"http:\/\/finservwealth.com\/quality-concerns-indian-drug-regulators-probing-209-risky-manufacturing-sites-45-in-himachal-get-notice\/"},"modified":"2023-06-23T17:40:41","modified_gmt":"2023-06-23T12:10:41","slug":"quality-concerns-indian-drug-regulators-probing-209-risky-manufacturing-sites-45-in-himachal-get-notice","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/quality-concerns-indian-drug-regulators-probing-209-risky-manufacturing-sites-45-in-himachal-get-notice\/","title":{"rendered":"Quality concerns: Indian drug regulators probing 209 risky manufacturing sites, 45 in Himachal get notice"},"content":{"rendered":"<p> The joint team comprising central and state drug regulators, after conducting inspections of 51 erring firms, the most in any state, has issued show-cause notices to 26 manufacturing units in the hill state.<\/p><div id=\"finse-3981514425\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/health\/quality-concerns-indian-drug-regulators-probing-209-risky-manufacturing-sites-45himachal-get-notice_17091911.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The joint team comprising central and state drug regulators, after conducting inspections of 51 erring firms, the most in any state, has issued show-cause notices to 26 manufacturing units in the hill state. The joint team comprising central and state drug regulators, after conducting inspections of 51 erring firms, the most in any state, has issued show-cause notices to 26 manufacturing units in the hill state.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/health\/quality-concerns-indian-drug-regulators-probing-209-risky-manufacturing-sites-45himachal-get-notice_17091911.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> The joint team comprising central and state drug regulators, after conducting inspections of 51 erring firms, the most in any state, has issued show-cause notices to 26 manufacturing units in the hill state.<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/health\/quality-concerns-indian-drug-regulators-probing-209-risky-manufacturing-sites-45himachal-get-notice_17091911.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The joint team comprising central and state drug regulators, after conducting inspections of 51 erring firms, the most in any state, has issued show-cause notices to 26 manufacturing units in the hill state. The joint team comprising central and state drug regulators, after conducting inspections of 51 erring firms, the most in any state, has issued show-cause notices to 26 manufacturing units in the hill state.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/health\/quality-concerns-indian-drug-regulators-probing-209-risky-manufacturing-sites-45himachal-get-notice_17091911.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> The joint team comprising central and state drug regulators, after conducting inspections of 51 erring firms, the most in any state, has issued show-cause notices to 26 manufacturing units in the hill state.<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-60600","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2017\/200x200\/G\/GettyImages-867017096_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/60600","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=60600"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/60600\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=60600"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=60600"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=60600"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}